Trial intelligence / Profile preview

Lenalidomide in Complex Regional Pain Syndrome Type 1

NCT00166452Phase 3Completed

Sponsor
Mayo Clinic
Start
Jul 2005
Primary completion
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lenalidomide in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by Mayo Clinic. Started Jul 2005; status: completed.

02

Drugs

lenalidomide
03

Conditions

Complex Regional Pain Syndrome Type 1 (CRPS-1)

Beyond the preview

Go deeper on NCT00166452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00166452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call